60 /100
HIGH RISK
Score updated Jul 14, 2026

VIVS — VivoSim Labs, Inc. Dilution Risk Tracker

Track VIVS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track VIVS — Get alerts when the score changes →

As of July 14, 2026, VivoSim Labs, Inc. (VIVS) has a DilutionWatch DilutionScore of 60/100, rated HIGH dilution risk. VivoSim Labs, Inc. has a market capitalization of $3.79M, 2.61M shares outstanding. Key dilution vectors include 8.6K outstanding warrants, approximately 12 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
65
📊 Float Risk
27
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
45%
🔁 Convertible Conversion 60%
• Major convertible overhang: 122% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split 40%
• 50-day avg $1.47 approaching $1 threshold
• 12 months cash with weak price
💰 Capital Raise 15%
• Under 12 months cash (12mo)
🔔 Track VIVS — Get forecast alerts →

💹 Market Data

Market Cap$3.79M
Shares Outstanding2.61M
Float2.33M
Cash$14.24M
Debt$812.0K
Short InterestN/A

🏛 Institutional Holdings

7.7% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track VIVS for full holder detail →

📉 Short Interest

Short Interest113.9K
Days to Cover1.0
% of Float4.9%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
xbrl XBRL CONVERTIBLE Mar 31, 2014
Full SEC filing analysis available with free account →

📰 Recent News

VivoSim Presents Data Showing Superiority to Competition in NAM Liver Tox Predic GlobeNewswire · Jun 29
VivoSim Platform Predicts Gastrointestinal Toxicity (Diarrhea) in an AI Model Tr GlobeNewswire · Apr 28
VivoSim Announces Pricing of up to a $4 Million Public Offering Yahoo Finance · Apr 01

📋 What This Means for VIVS Shareholders

VivoSim Labs, Inc. (VIVS) has a DilutionScore of 60/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

Cash runway is a key watch item: VIVS has approximately 12 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for VIVS in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for VIVS alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track VIVS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking VIVS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

AGMH ALLR AMSS APC APRE

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for VIVS
📊 VIVS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 VIVS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.